User profiles for Daniela Verthelyi

Daniela Verthelyi

FDA
Verified email at fda.hhs.gov
Cited by 9536

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

D Verthelyi, KJ Ishii, M Gursel, F Takeshita… - The Journal of …, 2001 - journals.aai.org
Oligodeoxynucleotides (ODN) that contain unmethylated CpG dinucleotides trigger a strong
innate immune response in vertebrates. CpG ODN show promise as vaccine adjuvants, anti-…

Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality

…, G Winter, YX Fan, S Kirshner, D Verthelyi… - Journal of …, 2009 - jpharmsci.org
Therapeutic protein products provide unique and effective treatments for numerous human
diseases and medical conditions. In many cases, these treatments are used chronically to …

Sex hormones as immunomodulators in health and disease

D Verthelyi - International immunopharmacology, 2001 - Elsevier
In addition to their effects on sexual differentiation and reproduction, sex hormones influence
the immune system. This results in a gender dimorphism in the immune function with …

Use of CpG oligodeoxynucleotides as immune adjuvants

…, D Currie, I Gursel, D Verthelyi - Immunological …, 2004 - Wiley Online Library
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs directly
stimulate human B cells and plasmacytoid dendritic cells (pDCs), thereby promoting the …

GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis

…, J Pedras-Vasconcelos, D Verthelyi… - The Journal of …, 2007 - journals.aai.org
Multiple sclerosis (MS) is a CNS autoimmune disease believed to be triggered by T cells
secreting Th1-specific proinflammatory cytokines, such as GM-CSF. In the animal model of MS, …

Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide

M Gürsel, D Verthelyi, I Gürsel, KJ Ishii… - Journal of Leukocyte …, 2002 - academic.oup.com
Synthetic oligodeoxynucleotides (ODN) expressing “CpG motifs” show promise as immune
adjuvants, antiallergens, anticancer, and immunoprotective agents. Two structurally distinct …

CpG oligodeoxynucleotides as vaccine adjuvants in primates

D Verthelyi, RT Kenney, RA Seder, AA Gam… - The journal of …, 2002 - journals.aai.org
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune
adjuvants in mice, boosting the humoral and cellular response to coadministered Ags. CpG …

[HTML][HTML] Lessons learned: new insights on the role of cytokines in COVID-19

…, JH Park, PL Schwartzberg, D Verthelyi… - Nature …, 2021 - nature.com
In the midst of resurging COVID-19 cases, the second NIH/FDA virtual COVID-19 and Cytokines
symposium was held on 1 December 2020, focusing on longitudinal studies of COVID-…

Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment

…, J Lozier, G Johnson, S Kirshner, D Verthelyi… - Nature …, 2008 - nature.com
Lysosomal storage diseases are characterized by deficiencies in lysosomal enzymes,
allowing accumulation of target substrate in cells and eventually causing cell death. Enzyme …

[HTML][HTML] Zika (PRVABC59) infection is associated with T cell infiltration and neurodegeneration in CNS of immunocompetent neonatal C57Bl/6 mice

M Manangeeswaran, DDC Ireland, D Verthelyi - PLoS pathogens, 2016 - journals.plos.org
The recent spread of Zika virus (ZIKV) and its association with increased rates of Guillain Barre
and other neurological disorders as well as congenital defects that include microcephaly …